Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of a key neuroendocrine molecule.
暂无分享,去创建一个
[1] R. Bucala,et al. Macrophage migration inhibitory factor. , 2005, Critical care medicine.
[2] E. Zeggini,et al. A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. , 2004, Arthritis and rheumatism.
[3] S. Liebhaber,et al. Activation of the human GH gene cluster: roles for targeted chromatin modification , 2004, Trends in Endocrinology & Metabolism.
[4] M. Nóbrega,et al. Scanning Human Gene Deserts for Long-Range Enhancers , 2003, Science.
[5] A. Silman,et al. Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis , 2003, Genes and Immunity.
[6] J. Bernhagen,et al. Regulated secretion of macrophage migration inhibitory factor is mediated by a non‐classical pathway involving an ABC transporter , 2003, FEBS letters.
[7] L. Leng,et al. MIF Signal Transduction Initiated by Binding to CD74 , 2003, The Journal of experimental medicine.
[8] W. Thomson,et al. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. , 2003, Arthritis and rheumatism.
[9] P. Gregersen,et al. Macrophage migration inhibitory factor, MIF alleles, and the genetics of inflammatory disorders: incorporating disease outcome into the definition of phenotype. , 2003, Arthritis and rheumatism.
[10] Diego G. Silva,et al. Macrophage migration inhibitory factor exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counter‐regulator , 2003, Immunology and cell biology.
[11] A. Masamune,et al. Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis. , 2003, Gastroenterology.
[12] R. Bucala,et al. Macrophage migration inhibitory factor: an emerging therapeutic target in rheumatoid arthritis. , 2003, Arthritis and rheumatism.
[13] E. Zeggini,et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. , 2002, Arthritis and rheumatism.
[14] W. Thomson,et al. Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum. , 2002, The Journal of rheumatology.
[15] G. Chrousos,et al. Stress Hormones, Proinflammatory and Antiinflammatory Cytokines, and Autoimmunity , 2002, Annals of the New York Academy of Sciences.
[16] P. Gregersen,et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis , 2002, Genes and Immunity.
[17] R. Bucala,et al. Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations. , 2002, Rheumatology.
[18] N. Petrovsky,et al. Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease. , 2002, The Journal of clinical endocrinology and metabolism.
[19] Y. D. Jong. Development of chronic colitis is dependent on the cytokine MIF , 2002, Nature Immunology.
[20] T. Calandra,et al. MIF regulates innate immune responses through modulation of Toll-like receptor 4 , 2001, Nature.
[21] Koichi Matsumoto,et al. Increased Production of Macrophage Migration Inhibitory Factor by T Cells in Patients with IgA Nephropathy , 2001, American Journal of Nephrology.
[22] D. Ray,et al. Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus. , 2001, Arthritis and rheumatism.
[23] Frank Dudbridge,et al. Haplotype tagging for the identification of common disease genes , 2001, Nature Genetics.
[24] G. Fingerle-Rowson,et al. Neuroendocrine properties of macrophage migration inhibitory factor (MIF) , 2001, Immunology and cell biology.
[25] M. Onji,et al. Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance , 2001, European journal of clinical investigation.
[26] R. Bucala,et al. Role of macrophage migration inhibitory factor (MIF) in murine antigen‐induced arthritis: interaction with glucocorticoids , 2001, Clinical and experimental immunology.
[27] J. Bernhagen,et al. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1 , 2000, Nature.
[28] S. Kikuchi,et al. Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behçet’s disease , 2000, Journal of the Neurological Sciences.
[29] J. Cannon,et al. Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IκBα , 2000 .
[30] R. Bucala,et al. Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritis. , 2000, Arthritis and rheumatism.
[31] M. Imamura,et al. Elevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetes. , 2000, Diabetes care.
[32] R. Bucala,et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor , 2000, Nature Medicine.
[33] R. Bucala,et al. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. , 1999, Arthritis and rheumatism.
[34] W. Johnson,et al. Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 A resolution: implications for enzymatic catalysis and inhibition. , 1999, Biochemistry.
[35] I. Tanaka,et al. Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution. , 1999, Biochemistry.
[36] M. Suarez‐Almazor,et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. , 1998, The Journal of rheumatology.
[37] J S Yudkin,et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. , 1998, The Journal of clinical investigation.
[38] C. Kozak,et al. Conserved gene structure and genomic linkage for D-dopachrome tautomerase (DDT) and MIF , 1998, Mammalian Genome.
[39] R. Kleemann,et al. Cross‐linking and mutational analysis of the oligomerization state of the cytokine macrophage migration inhibitory factor (MIF) , 1998, FEBS letters.
[40] R. Bucala,et al. Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. , 1998, Arthritis and rheumatism.
[41] G. Waeber,et al. Transcriptional activation of the macrophage migration-inhibitory factor gene by the corticotropin-releasing factor is mediated by the cyclic adenosine 3',5'- monophosphate responsive element-binding protein CREB in pituitary cells. , 1998, Molecular endocrinology.
[42] R. Bucala,et al. Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease. , 1997, Molecular medicine today.
[43] R. Holmdahl,et al. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. , 1997, Journal of immunology.
[44] C. Kozak,et al. Localization of the human gene for macrophage migration inhibitory factor (MIF) to chromosome 22q11.2. , 1997, Genomics.
[45] R. Bucala,et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[46] I. Tanaka,et al. Crystal structure of macrophage migration inhibitory factor from human Å lymphocyte at 2.1 Å resolution , 1996, FEBS letters.
[47] J. Bernhagen,et al. Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[48] Atsushi Nakagawa,et al. Crystal structure of the macrophage migration inhibitory factor from rat liver , 1996, Nature Structural Biology.
[49] Z. Dauter,et al. Enzymatic ketonization of 2-hydroxymuconate: specificity and mechanism investigated by the crystal structures of two isomerases. , 1996, Biochemistry.
[50] J. Bernhagen,et al. Localization of Macrophage Migration Inhibitory Factor (MIF) to Secretory Granules within the Corticotrophic and Thyrotrophic Cells of the Pituitary Gland , 1995, Molecular medicine.
[51] J. Bernhagen,et al. MIF as a glucocorticoid-induced modulator of cytokine production , 1995, Nature.
[52] L. Segovia,et al. Genomic cloning of mouse MIF (macrophage inhibitory factor) and genetic mapping of the human and mouse expressed gene and nine mouse pseudogenes. , 1995, Genomics.
[53] L. F. Kolakowski,et al. Structural characterization and chromosomal location of the mouse macrophage migration inhibitory factor gene and pseudogenes. , 1995, Genomics.
[54] M. Seldin,et al. Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF). , 1995, Journal of immunology.
[55] W. Lipscomb,et al. The monofunctional chorismate mutase from Bacillus subtilis. Structure determination of chorismate mutase and its complexes with a transition state analog and prephenate, and implications for the mechanism of the enzymatic reaction. , 1994, Journal of molecular biology.
[56] K. Tracey,et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia , 1993, Nature.
[57] J. David,et al. Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[58] M. A. Saper,et al. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens , 1987, Nature.
[59] J. David. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. , 1966, Proceedings of the National Academy of Sciences of the United States of America.
[60] B. Bloom,et al. Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity , 1966, Science.
[61] F. Dhabhar,et al. Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo. , 2003, The American journal of pathology.
[62] A. Martini,et al. Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis. , 2002, Arthritis and rheumatism.
[63] J. Cannon,et al. Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IkappaBalpha. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.
[64] V. Paralkar,et al. Cloning the human gene for macrophage migration inhibitory factor (MIF). , 1994, Genomics.
[65] J. David. Macrophage migration. , 1968, Federation proceedings.